Honda Evaluates CKD Return in India With ZR-V Hybrid SUV Expansion Strategy

Honda Cars India is evaluating the possibility of bringing back CKD (completely knocked down) premium models in India as part of a broader strategy to strengthen its passenger vehicle business and rebuild its premium product portfolio. The company indicated that the recently launched Honda ZR-V e:HEV premium SUV could become a key benchmark for assessing customer demand in the higher-end segment. A positive market response may encourage the automaker to consider wider localisation efforts and even resume assembly operations for imported premium products in the country.

Speaking about the possibility of reviving CKD models such as the Civic, Accord and CR-V in India, Honda Cars India President and CEO Takashi Nakajima confirmed that the company continues to study the option. According to Nakajima, Honda is actively evaluating opportunities in the premium space as part of its long-term strategy for the Indian market. The ZR-V launch marks Honda’s return to the premium import category after the discontinuation of models such as the Accord Hybrid and CR-V from the domestic lineup.

Honda Premium SUV Expansion Strategy in India

The newly introduced ZR-V e:HEV has been positioned above the Elevate SUV in Honda’s domestic portfolio. The premium hybrid SUV is aimed at customers seeking a refined five-seat SUV focused on comfort, hybrid efficiency and premium driving characteristics. Honda believes the ZR-V can provide valuable market insights regarding consumer appetite for premium hybrid products in India, especially as customer preferences gradually shift toward feature-rich and electrified vehicles.

Nakajima stated that if the ZR-V performs strongly in the Indian market, Honda could begin expanding production capabilities for additional premium products. The company is evaluating future growth opportunities while maintaining flexibility regarding local assembly and manufacturing operations. Honda currently operates manufacturing facilities in Greater Noida and Tapukara, Rajasthan, although production activities have been consolidated at the Tapukara facility due to lower domestic volumes in recent years.

Honda Manufacturing and CKD Assembly Possibilities

The Greater Noida facility still retains the capability to support CKD assembly operations if Honda decides to expand premium local assembly activities in the future. However, Nakajima did not disclose specific plans regarding factory utilisation or whether operations at Greater Noida could be restarted for premium model assembly. He reiterated that his immediate priority remains maximising the utilisation of the Tapukara manufacturing plant while the company evaluates long-term business opportunities in the Indian market.

Honda’s renewed interest in premium products comes at a time when the company is restructuring its India strategy after years of declining market share and a shrinking mass-market portfolio. The automaker currently sells the Elevate SUV, City sedan and Amaze compact sedan in India, leaving it absent from several rapidly expanding market segments, including sub-4-metre SUVs. The company is therefore focusing on product expansion and localisation to improve its competitive position.

Honda India Growth and Product Localisation Plans

Honda has identified India as one of its three core global markets alongside Japan and North America. The company plans to introduce India-focused products from 2028 onward while also increasing localisation levels to reduce costs and improve competitiveness. Alongside product development initiatives, Honda is also exploring partnerships within India to improve operational scale and optimise business efficiency.

Although the company has not disclosed the exact nature of these discussions, the collaborations could potentially involve technology sharing, cross-badging arrangements or powertrain supply agreements with other automotive manufacturers. Honda’s broader product expansion strategy for India includes the recently launched City facelift and the ZR-V hybrid SUV, both of which form part of a planned six-product rollout scheduled for the Indian market this year.

Frequently Asked Questions

Why is Honda considering bringing back CKD models in India?
Honda is evaluating CKD premium models in India to strengthen its product portfolio and improve its position in the passenger vehicle market. The company believes there may be growing demand for premium hybrid SUVs and imported models among Indian customers. By studying the market response to the ZR-V e:HEV, Honda can assess whether local assembly operations for products like the Civic, Accord and CR-V would become commercially viable. The strategy also supports Honda’s broader localisation and expansion goals in India.

What role does the Honda ZR-V e:HEV play in Honda’s India strategy?
The Honda ZR-V e:HEV is being used as a test case to evaluate customer demand for premium hybrid SUVs in India. Positioned above the Elevate SUV, the ZR-V targets buyers seeking refinement, comfort and electrified performance. Honda plans to use the model’s market response to determine future investment decisions related to premium products, localisation and possible CKD assembly expansion. The launch also marks Honda’s return to India’s premium import segment after discontinuing earlier premium models.